{"DataElement":{"publicId":"3147627","version":"1","preferredName":"EGFR Gene Assessment Mutation Abnormality Type","preferredDefinition":"The specific EGFR mutation identified.","longName":"3139428v1.0:3147620v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3139428","version":"1","preferredName":"Mutation Abnormality EGFR Gene Status Assessment","preferredDefinition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._A condition or state at a particular time._The EGFR gene at chromosome 7p12.3-p12.1 encodes the EGFreceptor, a cell surface transmembrane protein tyrosine kinase involved in regulation of cell growth and differentiation. The gene is not expressed in mitotically quiescent cells, except in the stomach where it controls the synthesis and release of digestive enzymes and gastric acid. EGFR tyrosine kinase activity is required for internalization or degradation of EGF-EGFR receptor complexes. EGFR signaling involves small RHO GTPases and EGFR trafficking involves small RAB GTPases._The final result of a determination of the value, significance, or extent of.","longName":"3140537v1.0:2465182v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3140537","version":"1","preferredName":"Mutation Abnormality Status EGFR Gene","preferredDefinition":"A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically.:A condition or state at a particular time.:The EGFR gene at chromosome 7p12.3-p12.1 encodes the EGFreceptor, a cell surface transmembrane protein tyrosine kinase involved in regulation of cell growth and differentiation. The gene is not expressed in mitotically quiescent cells, except in the stomach where it controls the synthesis and release of digestive enzymes and gastric acid. EGFR tyrosine kinase activity is required for internalization or degradation of EGF-EGFR receptor complexes. EGFR signaling involves small RHO GTPases and EGFR trafficking involves small RAB GTPases.","longName":"C45576:C25688:C17757","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"EGFR Gene","conceptCode":"C17757","definition":"This gene is involved in the epidermal growth factor signal transduction pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90CB2498-1311-F587-E040-BB89AD4345F0","latestVersionIndicator":"Yes","beginDate":"2010-09-21","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-21","modifiedBy":"ONEDATA","dateModified":"2010-09-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2465182","version":"1","preferredName":"Assessed","preferredDefinition":"Having determined the value, significance, or extent of.","longName":"C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F836E72-26FF-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-03-22","modifiedBy":"ONEDATA","dateModified":"2006-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B8A833-01A1-5148-E040-BB89AD4346DE","latestVersionIndicator":"Yes","beginDate":"2010-09-20","endDate":null,"createdBy":"WHITES","dateCreated":"2010-09-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of S.Ratliff. 09/2010 sw.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3147620","version":"1","preferredName":"EGFR Gene Mutation Abnormality Type","preferredDefinition":"The EGFR gene at chromosome 7p12.3-p12.1 encodes the EGFreceptor, a cell surface transmembrane protein tyrosine kinase involved in regulation of cell growth and differentiation. The gene is not expressed in mitotically quiescent cells, except in the stomach where it controls the synthesis and release of digestive enzymes and gastric acid. EGFR tyrosine kinase activity is required for internalization or degradation of EGF-EGFR receptor complexes. EGFR signaling involves small RHO GTPases and EGFR trafficking involves small RAB GTPases._A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically._Type; a subdivision of a particular kind of thing.","longName":"3147620v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"5","maxLength":"17","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Exon 19 Deletion","valueDescription":"Exon 19 Deletion Mutation","ValueMeaning":{"publicId":"3147622","version":"1","preferredName":"Exon 19 Deletion Mutation","longName":"3147622","preferredDefinition":"The sequences of a gene that are present in the final, mature, spliced messenger RNA molecule from that gene.: A number with no fractional part, including the negative and positive numbers as well as zero.::19: Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Exon","conceptCode":"C13231","definition":"The sequences of a gene that are present in the final, mature, spliced messenger RNA molecule from that gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Deletion Mutation","conceptCode":"C19296","definition":"Any rearrangement to the genomic content that results in the loss of one or more nucleotides of DNA. Deletions are generally irreversible rearrangements. They may alter the reading frame of a gene, or may result in loss of large chromosomal regions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"91F4555F-4DCF-05CE-E040-BB89AD43554F","latestVersionIndicator":"Yes","beginDate":"2010-10-06","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-06","modifiedBy":"SOKKERL","dateModified":"2019-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"921F701D-1539-099F-E040-BB89AD432B50","beginDate":"2010-10-06","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-08","modifiedBy":"ONEDATA","dateModified":"2010-10-08","deletedIndicator":"No"},{"value":"Exon 20 Insertion","valueDescription":"Exon Integer::20 Insertion Mutation","ValueMeaning":{"publicId":"3147621","version":"1","preferredName":"Exon Integer::20 Insertion Mutation","longName":"3147621","preferredDefinition":"The sequences of a gene that are present in the final, mature, spliced messenger RNA molecule from that gene.: A number with no fractional part.::20: Mutations that result in the insertion of one or more nucleotides into a wild type DNA sequence.  Can result in a frame shift in the coding sequence of a gene.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Exon","conceptCode":"C13231","definition":"The sequences of a gene that are present in the final, mature, spliced messenger RNA molecule from that gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Insertion Mutation","conceptCode":"C19295","definition":"Any rearrangement to the genomic content that adds one or more extra nucleotides into the DNA. Insertions may be reversible, particulary if caused by transposable elements. They may alter the reading frame of a gene, or may cause large scale additions of genomic DNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"91F4555F-4DA8-05CE-E040-BB89AD43554F","latestVersionIndicator":"Yes","beginDate":"2010-10-06","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"921F701D-154D-099F-E040-BB89AD432B50","beginDate":"2010-10-06","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-08","modifiedBy":"ONEDATA","dateModified":"2010-10-08","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"91F4555F-4DF2-05CE-E040-BB89AD43554F","beginDate":"2010-10-06","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-06","modifiedBy":"ONEDATA","dateModified":"2010-10-06","deletedIndicator":"No"},{"value":"L861Q","valueDescription":"L861Q","ValueMeaning":{"publicId":"3147623","version":"1","preferredName":"L861Q","longName":"3147623","preferredDefinition":"A change in the amino acid residue at position 861 in the epidermal growth factor receptor protein where leucine has been replaced by glutamine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.L861Q","conceptCode":"C98497","definition":"A change in the amino acid residue at position 861 in the epidermal growth factor receptor protein where leucine has been replaced by glutamine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"91F4555F-4DFC-05CE-E040-BB89AD43554F","latestVersionIndicator":"Yes","beginDate":"2010-10-06","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"91F4555F-4E15-05CE-E040-BB89AD43554F","beginDate":"2010-10-06","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-06","modifiedBy":"ONEDATA","dateModified":"2010-10-06","deletedIndicator":"No"},{"value":"L858R","valueDescription":"L858R","ValueMeaning":{"publicId":"3147624","version":"1","preferredName":"L858R","longName":"3147624","preferredDefinition":"A change in the amino acid residue at position 858 in the epidermal growth factor receptor protein where leucine has been replaced by arginine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.L858R","conceptCode":"C98515","definition":"A change in the amino acid residue at position 858 in the epidermal growth factor receptor protein where leucine has been replaced by arginine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"91F4555F-4E1F-05CE-E040-BB89AD43554F","latestVersionIndicator":"Yes","beginDate":"2010-10-06","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-06","modifiedBy":"SOKKERL","dateModified":"2019-01-04","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"91F4555F-4E38-05CE-E040-BB89AD43554F","beginDate":"2010-10-06","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-06","modifiedBy":"ONEDATA","dateModified":"2010-10-06","deletedIndicator":"No"},{"value":"T790M","valueDescription":"T790M","ValueMeaning":{"publicId":"3147625","version":"1","preferredName":"T790M","longName":"3147625","preferredDefinition":"A change in the amino acid residue at position 790 in the epidermal growth factor receptor protein where threonine has been replaced by methionine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.T790M","conceptCode":"C98503","definition":"A change in the amino acid residue at position 790 in the epidermal growth factor receptor protein where threonine has been replaced by methionine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"91F4555F-4E42-05CE-E040-BB89AD43554F","latestVersionIndicator":"Yes","beginDate":"2010-10-06","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"91F4555F-4E5B-05CE-E040-BB89AD43554F","beginDate":"2010-10-06","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-06","modifiedBy":"ONEDATA","dateModified":"2010-10-06","deletedIndicator":"No"},{"value":"G719X","valueDescription":"G719X","ValueMeaning":{"publicId":"3147626","version":"1","preferredName":"G719X","longName":"3147626","preferredDefinition":"A change in the amino acid residue at position 719 in the epidermal growth factor receptor protein where glycine has been replaced by another amino acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.G719X","conceptCode":"C107154","definition":"A change in the amino acid residue at position 719 in the epidermal growth factor receptor protein where glycine has been replaced by another amino acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"91F4555F-4E65-05CE-E040-BB89AD43554F","latestVersionIndicator":"Yes","beginDate":"2010-10-06","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"91F4555F-4E7E-05CE-E040-BB89AD43554F","beginDate":"2010-10-06","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-06","modifiedBy":"ONEDATA","dateModified":"2010-10-06","deletedIndicator":"No"},{"value":"S768I","valueDescription":"EGFR NP_005219.2:p.S768I","ValueMeaning":{"publicId":"6112317","version":"1","preferredName":"EGFR NP_005219.2:p.S768I","longName":"6112317","preferredDefinition":"A change in the amino acid residue at position 768 in the epidermal growth factor receptor protein where serine has been replaced by isoleucine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.S768I","conceptCode":"C125210","definition":"A change in the amino acid residue at position 768 in the epidermal growth factor receptor protein where serine has been replaced by isoleucine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66C4C9AF-D7EB-3F51-E053-F662850A681C","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66C4C9AF-D804-3F51-E053-F662850A681C","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","deletedIndicator":"No"},{"value":"L792Y","valueDescription":"EGFR NP_005219.2:p.L792Y","ValueMeaning":{"publicId":"6112318","version":"1","preferredName":"EGFR NP_005219.2:p.L792Y","longName":"6112318","preferredDefinition":"A change in the amino acid residue at position 792 in the epidermal growth factor receptor protein where leucine has been replaced by tyrosine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.L792Y","conceptCode":"C147017","definition":"A change in the amino acid residue at position 792 in the epidermal growth factor receptor protein where leucine has been replaced by tyrosine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66C4C9AF-D810-3F51-E053-F662850A681C","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66C4C9AF-D829-3F51-E053-F662850A681C","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","deletedIndicator":"No"},{"value":"G796R","valueDescription":"EGFR NP_005219.2:p.G796R","ValueMeaning":{"publicId":"6112319","version":"1","preferredName":"EGFR NP_005219.2:p.G796R","longName":"6112319","preferredDefinition":"A change in the amino acid residue at position 796 in the epidermal growth factor receptor protein where glycine has been replaced by arginine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.G796R","conceptCode":"C147025","definition":"A change in the amino acid residue at position 796 in the epidermal growth factor receptor protein where glycine has been replaced by arginine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66C4C9AF-D835-3F51-E053-F662850A681C","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66C4C9AF-D84E-3F51-E053-F662850A681C","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","deletedIndicator":"No"},{"value":"G796S","valueDescription":"EGFR NP_005219.2:p.G796S","ValueMeaning":{"publicId":"6112320","version":"1","preferredName":"EGFR NP_005219.2:p.G796S","longName":"6112320","preferredDefinition":"A change in the amino acid residue at position 796 in the epidermal growth factor receptor protein where glycine has been replaced by serine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.G796S","conceptCode":"C147023","definition":"A change in the amino acid residue at position 796 in the epidermal growth factor receptor protein where glycine has been replaced by serine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66C4C9AF-D85A-3F51-E053-F662850A681C","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66C4C9AF-D873-3F51-E053-F662850A681C","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","deletedIndicator":"No"},{"value":"L718Q","valueDescription":"EGFR NP_005219.2:p.L718Q","ValueMeaning":{"publicId":"6112321","version":"1","preferredName":"EGFR NP_005219.2:p.L718Q","longName":"6112321","preferredDefinition":"A change in the amino acid residue at position 718 in the epidermal growth factor receptor protein where leucine has been replaced by glutamine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.L718Q","conceptCode":"C147021","definition":"A change in the amino acid residue at position 718 in the epidermal growth factor receptor protein where leucine has been replaced by glutamine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66C4C9AF-D87F-3F51-E053-F662850A681C","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66C4C9AF-D898-3F51-E053-F662850A681C","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","deletedIndicator":"No"},{"value":"L718V","valueDescription":"EGFR NP_005219.2:p.L718V","ValueMeaning":{"publicId":"6112322","version":"1","preferredName":"EGFR NP_005219.2:p.L718V","longName":"6112322","preferredDefinition":"A change in the amino acid residue at position 718 in the epidermal growth factor receptor protein where leucine has been replaced by valine","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.L718V","conceptCode":"C147018","definition":"A change in the amino acid residue at position 718 in the epidermal growth factor receptor protein where leucine has been replaced by valine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66C4C9AF-D8A4-3F51-E053-F662850A681C","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66C4C9AF-D8BD-3F51-E053-F662850A681C","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","deletedIndicator":"No"},{"value":"L792H","valueDescription":"EGFR NP_005219.2:p.L792H","ValueMeaning":{"publicId":"6112323","version":"1","preferredName":"EGFR NP_005219.2:p.L792H","longName":"6112323","preferredDefinition":"A change in the amino acid residue at position 792 in the epidermal growth factor receptor protein where leucine has been replaced by histidine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.L792H","conceptCode":"C147016","definition":"A change in the amino acid residue at position 792 in the epidermal growth factor receptor protein where leucine has been replaced by histidine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66C4C9AF-D8C9-3F51-E053-F662850A681C","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66C4C9AF-D8E2-3F51-E053-F662850A681C","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","deletedIndicator":"No"},{"value":"L792F","valueDescription":"EGFR NP_005219.2:p.L792F","ValueMeaning":{"publicId":"6112324","version":"1","preferredName":"EGFR NP_005219.2:p.L792F","longName":"6112324","preferredDefinition":"A change in the amino acid residue at position 792 in the epidermal growth factor receptor protein where leucine has been replaced by phenylalanine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.L792F","conceptCode":"C147014","definition":"A change in the amino acid residue at position 792 in the epidermal growth factor receptor protein where leucine has been replaced by phenylalanine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66C4C9AF-D8EE-3F51-E053-F662850A681C","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66C4C9AF-D907-3F51-E053-F662850A681C","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","deletedIndicator":"No"},{"value":"C797A","valueDescription":"EGFR NP_005219.2:p.C797A","ValueMeaning":{"publicId":"6112325","version":"1","preferredName":"EGFR NP_005219.2:p.C797A","longName":"6112325","preferredDefinition":"A change in the amino acid residue at position 797 in the epidermal growth factor receptor protein where cysteine has been replaced by alanine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.C797A","conceptCode":"C147012","definition":"A change in the amino acid residue at position 797 in the epidermal growth factor receptor protein where cysteine has been replaced by alanine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66C4C9AF-D913-3F51-E053-F662850A681C","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66C4C9AF-D92C-3F51-E053-F662850A681C","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","deletedIndicator":"No"},{"value":"C797S","valueDescription":"EGFR NP_005219.2:p.C797S","ValueMeaning":{"publicId":"6112326","version":"1","preferredName":"EGFR NP_005219.2:p.C797S","longName":"6112326","preferredDefinition":"A change in the amino acid residue at position 797 in the epidermal growth factor receptor protein where cysteine has been replaced by serine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.C797S","conceptCode":"C147011","definition":"A change in the amino acid residue at position 797 in the epidermal growth factor receptor protein where cysteine has been replaced by serine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66C4C9AF-D938-3F51-E053-F662850A681C","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"COLBERTM","dateModified":"2019-02-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66C4C9AF-D951-3F51-E053-F662850A681C","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","deletedIndicator":"No"},{"value":"L718X","valueDescription":"EGFR NP_005219.2:p.L718X","ValueMeaning":{"publicId":"6112330","version":"1","preferredName":"EGFR NP_005219.2:p.L718X","longName":"6112330","preferredDefinition":"A change in the amino acid residue at position 718 in the epidermal growth factor receptor protein where leucine has been replaced by another amino acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.L718X","conceptCode":"C147133","definition":"A change in the amino acid residue at position 718 in the epidermal growth factor receptor protein where leucine has been replaced by another amino acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66C63606-3FC8-580D-E053-F662850A84F4","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66C63606-3FE1-580D-E053-F662850A84F4","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","deletedIndicator":"No"},{"value":"G796X","valueDescription":"EGFR NP_005219.2:p.G796X","ValueMeaning":{"publicId":"6112331","version":"1","preferredName":"EGFR NP_005219.2:p.G796X","longName":"6112331","preferredDefinition":"A change in the amino acid residue at position 796 in the epidermal growth factor receptor protein where glycine has been replaced by another amino acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.G796X","conceptCode":"C147132","definition":"A change in the amino acid residue at position 796 in the epidermal growth factor receptor protein where glycine has been replaced by another amino acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66C63606-3FED-580D-E053-F662850A84F4","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66C63606-4006-580D-E053-F662850A84F4","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","deletedIndicator":"No"},{"value":"L792X","valueDescription":"EGFR NP_005219.2:p.L792X","ValueMeaning":{"publicId":"6112332","version":"1","preferredName":"EGFR NP_005219.2:p.L792X","longName":"6112332","preferredDefinition":"A change in the amino acid residue at position 792 in the epidermal growth factor receptor protein where leucine has been replaced by another amino acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR NP_005219.2:p.L792X","conceptCode":"C147131","definition":"A change in the amino acid residue at position 792 in the epidermal growth factor receptor protein where leucine has been replaced by another amino acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66C63606-4012-580D-E053-F662850A84F4","latestVersionIndicator":"Yes","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66C63606-402B-580D-E053-F662850A84F4","beginDate":"2018-03-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-03-06","modifiedBy":"ONEDATA","dateModified":"2018-03-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3147619","version":"1","preferredName":"EGFR Gene Mutation Abnormality Type","preferredDefinition":"The EGFR gene at chromosome 7p12.3-p12.1 encodes the EGFreceptor, a cell surface transmembrane protein tyrosine kinase involved in regulation of cell growth and differentiation. The gene is not expressed in mitotically quiescent cells, except in the stomach where it controls the synthesis and release of digestive enzymes and gastric acid. EGFR tyrosine kinase activity is required for internalization or degradation of EGF-EGFR receptor complexes. EGFR signaling involves small RHO GTPases and EGFR trafficking involves small RAB GTPases.:A general term referring to single or multiple alterations in the genetic material of an organism that ranges from a single base change in a gene to the loss or addition of complete chromosomes. A mutation abnormality may be heritable or occur somatically.:Type; a subdivision of a particular kind of thing.","longName":"C17757:C45576:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"EGFR Gene","conceptCode":"C17757","definition":"This gene is involved in the epidermal growth factor signal transduction pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"91F4555F-4D7B-05CE-E040-BB89AD43554F","latestVersionIndicator":"Yes","beginDate":"2010-10-06","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-06","modifiedBy":"ONEDATA","dateModified":"2010-10-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"91F4555F-4D8C-05CE-E040-BB89AD43554F","latestVersionIndicator":"Yes","beginDate":"2010-10-06","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-06","modifiedBy":"SOKKERL","dateModified":"2019-04-04","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of S.Ratliff 10/2010 sw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787513","version":"1","longName":"LUSC","context":"NCIP"},{"publicId":"3787512","version":"1","longName":"LUAD","context":"NCIP"}]},{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000003","version":"1","longName":"Lung","context":"OCG"}]}],"AlternateNames":[{"name":"egfr_mutation_result","type":"TCGA_XML_Name","context":"NCIP"},{"name":"SWOG","type":"USED_BY","context":"SWOG"},{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"EGFR_mutation_result","type":"HCMI Name","context":"OCG"},{"name":"Theradex","type":"USED_BY","context":"Theradex"}],"ReferenceDocuments":[{"name":"If EGFR Mutation Identified,","type":"Preferred Question Text","description":"If EGFR Mutation Identified, Which One?","url":null,"context":"NCIP"},{"name":"EGFR mutation type","type":"Alternate Question Text","description":"EGFR mutation type","url":null,"context":"SWOG"},{"name":"HCMI Question Text","type":"Alternate Question Text","description":"If EGFR mutation identified, which one?","url":null,"context":"OCG"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"EGFR mutation status","url":null,"context":"Theradex"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"91F4555F-4E88-05CE-E040-BB89AD43554F","latestVersionIndicator":"Yes","beginDate":"2010-10-06","endDate":null,"createdBy":"WHITES","dateCreated":"2010-10-06","modifiedBy":"SOKKERL","dateModified":"2019-01-04","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of S.Ratliff 10/2010 sw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}